Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

NCT01074060 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma
Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: plerixafor
BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
PROCEDURE: autologous hematopoietic stem cell transplantation
OTHER: laboratory biomarker analysis

Sponsor

City of Hope Medical Center